immune-mediated cardiomyopathy(English)

• patients have a higher risk of MACE despite similar LVEF trajectories compared with non-immune DCM controls
• CPM, DCM, DCMI, DCMP, LVEF, MACE
• Cardiology, Pathology, Immunology
• https://doi.org…93/ejhf/xuaf030